New Research Reveals Microglia’s Role in Alzheimer’s Lipid Balance

Research from UT Health San Antonio, in collaboration with the University of California at Irvine, has uncovered significant insights into how targeting brain immune cells may help restore lipid imbalances associated with Alzheimer’s disease. This study emphasizes the critical role of lipids in the disease’s development, a factor that has been largely overlooked in past research primarily focused on amyloid and tau proteins.

The findings, published in Nature Communications, indicate that disruptions in brain lipids can have a profound impact on the accumulation of amyloid proteins. Certain genes involved in lipid metabolism are also linked to an increased risk of Alzheimer’s.

Juan Pablo Palavicini, Ph.D., an assistant professor in the Department of Cellular and Integrative Physiology at UT Health San Antonio’s Long School of Medicine, co-led the study. He noted, “The brain is a unique organ. Unlike most other organs, which are rich in protein, more than half of the brain’s dry weight is made up of different kinds of lipids, including cholesterol and phospholipids.”

The study reveals that microglia, the brain’s immune cells, regulate lipid changes that are crucial for understanding Alzheimer’s pathology. Depending on how these cells are manipulated, they can either maintain lipid balance or exacerbate the disease.

Investigating Microglial Functions

Using a mouse model of Alzheimer’s, researchers tested two methods of removing microglia: one involved a drug that nearly eliminated all microglia, while the other utilized genetically modified mice that lacked these cells entirely. This approach helped scientists differentiate the effects of microglia from those of other brain cells.

“We wanted to understand which cells are driving these lipid changes,” explained Palavicini. The results showed that some lipids increased while others decreased, prompting the researchers to identify the specific cell types involved in these alterations.

The study compared the mouse data with post-mortem brain samples from individuals with and without Alzheimer’s. The results indicated that amyloid buildup significantly changed brain lipid patterns. Notably, two groups of lipids—lysophospholipids, which are linked to inflammation, and bis(monoacylglycero)phosphate (BMP), essential for regulating the brain’s lysosomes—were highlighted.

The accumulation of a form of BMP known as arachidonic acid-BMP (AA-BMP) was found near amyloid plaques. Long-term removal of microglia prevented the buildup of AA-BMP, suggesting that microglia are instrumental in these processes.

Progranulin’s Role in Lipid Regulation

Another significant finding was the role of the protein progranulin, produced by both microglia and neurons, as a key regulator of lipid balance. The study revealed that levels of progranulin increase in Alzheimer’s conditions and align closely with the accumulation of AA-BMP. Researchers found that when microglia were removed, both progranulin and AA-BMP levels decreased near amyloid plaques, indicating that microglial-derived progranulin is crucial for lipid regulation.

“Rather than lowering BMP, it may be important to maintain or support its levels,” Palavicini stated. “Progranulin helps maintain this lipid and protect neurons. Therapies that boost progranulin could potentially restore balance and support brain health.”

The research also indicated that not all lipid changes are governed by microglia. For instance, levels of lysophospholipids were primarily influenced by astrocytes and neurons. The team found that the buildup of lysophospholipids was associated with astrocyte activation and related enzyme activity, while the increase of other lipids was linked to oxidative stress.

Implications for Alzheimer’s Research

This study broadens the current understanding of Alzheimer’s, revealing that the disease is not solely defined by amyloid plaques and tau tangles. It illustrates the importance of lipid metabolism, with microglia, astrocytes, and neurons each contributing differently to lipid regulation.

The research underscores that microglia play a vital role in maintaining protective lipids such as BMP and supporting myelin, the protective sheath around neurons. When microglia were genetically removed, researchers observed a reduction in myelin-related lipids, suggesting that these immune cells are essential for brain lipid metabolism.

Palavicini concluded, “Understanding which cells regulate which lipids opens the door to more precise therapies. By targeting lipid balance alongside amyloid and tau, we can develop better strategies to protect neurons and potentially slow or prevent Alzheimer’s disease.”

This comprehensive look into lipid dynamics in Alzheimer’s disease not only highlights the complexities of brain cell interactions but also paves the way for innovative therapeutic approaches that could significantly impact patient care and treatment outcomes.